Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market
As the global economy mends, the 2021 growth of 13-Valent Pneumococcal Polysaccharide Conjugate V ... Read More
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global 23-valent Pneumococcal Vaccine Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for 23-valent Pneumococcal Vaccine by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for 23-valent Pneumococcal Vaccine by Country/Region, 2017, 2022 & 2028 2.2 23-valent Pneumococcal Vaccine Segment by Type 2.2.1 Single Dose Vial 2.2.2 Pre-filled Syringe 2.3 23-valent Pneumococcal Vaccine Sales by Type 2.3.1 Global 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022) 2.3.2 Global 23-valent Pneumococcal Vaccine Revenue and Market Share by Type (2017-2022) 2.3.3 Global 23-valent Pneumococcal Vaccine Sale Price by Type (2017-2022) 2.4 23-valent Pneumococcal Vaccine Segment by Application 2.4.1 Chronic Cardiovascular Disease 2.4.2 Chronic Lung Disease 2.4.3 Chronic Liver Disease 2.4.4 People Living with Hiv 2.4.5 Leukemia 2.4.6 Lymphoma 2.4.7 Multiple Myeloma 2.4.8 General Malignancy 2.4.9 Chronic Kidney Disease 2.4.10 Other 2.5 23-valent Pneumococcal Vaccine Sales by Application 2.5.1 Global 23-valent Pneumococcal Vaccine Sale Market Share by Application (2017-2022) 2.5.2 Global 23-valent Pneumococcal Vaccine Revenue and Market Share by Application (2017-2022) 2.5.3 Global 23-valent Pneumococcal Vaccine Sale Price by Application (2017-2022) 3 Global 23-valent Pneumococcal Vaccine by Company 3.1 Global 23-valent Pneumococcal Vaccine Breakdown Data by Company 3.1.1 Global 23-valent Pneumococcal Vaccine Annual Sales by Company (2020-2022) 3.1.2 Global 23-valent Pneumococcal Vaccine Sales Market Share by Company (2020-2022) 3.2 Global 23-valent Pneumococcal Vaccine Annual Revenue by Company (2020-2022) 3.2.1 Global 23-valent Pneumococcal Vaccine Revenue by Company (2020-2022) 3.2.2 Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company (2020-2022) 3.3 Global 23-valent Pneumococcal Vaccine Sale Price by Company 3.4 Key Manufacturers 23-valent Pneumococcal Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers 23-valent Pneumococcal Vaccine Product Location Distribution 3.4.2 Players 23-valent Pneumococcal Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for 23-valent Pneumococcal Vaccine by Geographic Region 4.1 World Historic 23-valent Pneumococcal Vaccine Market Size by Geographic Region (2017-2022) 4.1.1 Global 23-valent Pneumococcal Vaccine Annual Sales by Geographic Region (2017-2022) 4.1.2 Global 23-valent Pneumococcal Vaccine Annual Revenue by Geographic Region 4.2 World Historic 23-valent Pneumococcal Vaccine Market Size by Country/Region (2017-2022) 4.2.1 Global 23-valent Pneumococcal Vaccine Annual Sales by Country/Region (2017-2022) 4.2.2 Global 23-valent Pneumococcal Vaccine Annual Revenue by Country/Region 4.3 Americas 23-valent Pneumococcal Vaccine Sales Growth 4.4 APAC 23-valent Pneumococcal Vaccine Sales Growth 4.5 Europe 23-valent Pneumococcal Vaccine Sales Growth 4.6 Middle East & Africa 23-valent Pneumococcal Vaccine Sales Growth 5 Americas 5.1 Americas 23-valent Pneumococcal Vaccine Sales by Country 5.1.1 Americas 23-valent Pneumococcal Vaccine Sales by Country (2017-2022) 5.1.2 Americas 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022) 5.2 Americas 23-valent Pneumococcal Vaccine Sales by Type 5.3 Americas 23-valent Pneumococcal Vaccine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC 23-valent Pneumococcal Vaccine Sales by Region 6.1.1 APAC 23-valent Pneumococcal Vaccine Sales by Region (2017-2022) 6.1.2 APAC 23-valent Pneumococcal Vaccine Revenue by Region (2017-2022) 6.2 APAC 23-valent Pneumococcal Vaccine Sales by Type 6.3 APAC 23-valent Pneumococcal Vaccine Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe 23-valent Pneumococcal Vaccine by Country 7.1.1 Europe 23-valent Pneumococcal Vaccine Sales by Country (2017-2022) 7.1.2 Europe 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022) 7.2 Europe 23-valent Pneumococcal Vaccine Sales by Type 7.3 Europe 23-valent Pneumococcal Vaccine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa 23-valent Pneumococcal Vaccine by Country 8.1.1 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Country (2017-2022) 8.1.2 Middle East & Africa 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022) 8.2 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Type 8.3 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of 23-valent Pneumococcal Vaccine 10.3 Manufacturing Process Analysis of 23-valent Pneumococcal Vaccine 10.4 Industry Chain Structure of 23-valent Pneumococcal Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 23-valent Pneumococcal Vaccine Distributors 11.3 23-valent Pneumococcal Vaccine Customer 12 World Forecast Review for 23-valent Pneumococcal Vaccine by Geographic Region 12.1 Global 23-valent Pneumococcal Vaccine Market Size Forecast by Region 12.1.1 Global 23-valent Pneumococcal Vaccine Forecast by Region (2023-2028) 12.1.2 Global 23-valent Pneumococcal Vaccine Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global 23-valent Pneumococcal Vaccine Forecast by Type 12.7 Global 23-valent Pneumococcal Vaccine Forecast by Application 13 Key Players Analysis 13.1 Merck 13.1.1 Merck Company Information 13.1.2 Merck 23-valent Pneumococcal Vaccine Product Offered 13.1.3 Merck 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 Merck Main Business Overview 13.1.5 Merck Latest Developments 13.2 Sanofipasteur 13.2.1 Sanofipasteur Company Information 13.2.2 Sanofipasteur 23-valent Pneumococcal Vaccine Product Offered 13.2.3 Sanofipasteur 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 Sanofipasteur Main Business Overview 13.2.5 Sanofipasteur Latest Developments 13.3 CDIBP 13.3.1 CDIBP Company Information 13.3.2 CDIBP 23-valent Pneumococcal Vaccine Product Offered 13.3.3 CDIBP 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 CDIBP Main Business Overview 13.3.5 CDIBP Latest Developments 13.4 Kexing Bio 13.4.1 Kexing Bio Company Information 13.4.2 Kexing Bio 23-valent Pneumococcal Vaccine Product Offered 13.4.3 Kexing Bio 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 Kexing Bio Main Business Overview 13.4.5 Kexing Bio Latest Developments 13.5 Changsheng Bio-Technology 13.5.1 Changsheng Bio-Technology Company Information 13.5.2 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Offered 13.5.3 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.5.4 Changsheng Bio-Technology Main Business Overview 13.5.5 Changsheng Bio-Technology Latest Developments 13.6 Huaan Science and Technology Innovation 13.6.1 Huaan Science and Technology Innovation Company Information 13.6.2 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Offered 13.6.3 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.6.4 Huaan Science and Technology Innovation Main Business Overview 13.6.5 Huaan Science and Technology Innovation Latest Developments 14 Research Findings and Conclusion
List of Tables Table 1. 23-valent Pneumococcal Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. 23-valent Pneumococcal Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of Single Dose Vial Table 4. Major Players of Pre-filled Syringe Table 5. Global 23-valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units) Table 6. Global 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022) Table 7. Global 23-valent Pneumococcal Vaccine Revenue by Type (2017-2022) & ($ million) Table 8. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Type (2017-2022) Table 9. Global 23-valent Pneumococcal Vaccine Sale Price by Type (2017-2022) & (US$/Unit) Table 10. Global 23-valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units) Table 11. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022) Table 12. Global 23-valent Pneumococcal Vaccine Revenue by Application (2017-2022) Table 13. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Application (2017-2022) Table 14. Global 23-valent Pneumococcal Vaccine Sale Price by Application (2017-2022) & (US$/Unit) Table 15. Global 23-valent Pneumococcal Vaccine Sales by Company (2020-2022) & (K Units) Table 16. Global 23-valent Pneumococcal Vaccine Sales Market Share by Company (2020-2022) Table 17. Global 23-valent Pneumococcal Vaccine Revenue by Company (2020-2022) ($ Millions) Table 18. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company (2020-2022) Table 19. Global 23-valent Pneumococcal Vaccine Sale Price by Company (2020-2022) & (US$/Unit) Table 20. Key Manufacturers 23-valent Pneumococcal Vaccine Producing Area Distribution and Sales Area Table 21. Players 23-valent Pneumococcal Vaccine Products Offered Table 22. 23-valent Pneumococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global 23-valent Pneumococcal Vaccine Sales by Geographic Region (2017-2022) & (K Units) Table 26. Global 23-valent Pneumococcal Vaccine Sales Market Share Geographic Region (2017-2022) Table 27. Global 23-valent Pneumococcal Vaccine Revenue by Geographic Region (2017-2022) & ($ millions) Table 28. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Geographic Region (2017-2022) Table 29. Global 23-valent Pneumococcal Vaccine Sales by Country/Region (2017-2022) & (K Units) Table 30. Global 23-valent Pneumococcal Vaccine Sales Market Share by Country/Region (2017-2022) Table 31. Global 23-valent Pneumococcal Vaccine Revenue by Country/Region (2017-2022) & ($ millions) Table 32. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Country/Region (2017-2022) Table 33. Americas 23-valent Pneumococcal Vaccine Sales by Country (2017-2022) & (K Units) Table 34. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Country (2017-2022) Table 35. Americas 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 36. Americas 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2017-2022) Table 37. Americas 23-valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units) Table 38. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022) Table 39. Americas 23-valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units) Table 40. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022) Table 41. APAC 23-valent Pneumococcal Vaccine Sales by Region (2017-2022) & (K Units) Table 42. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Region (2017-2022) Table 43. APAC 23-valent Pneumococcal Vaccine Revenue by Region (2017-2022) & ($ Millions) Table 44. APAC 23-valent Pneumococcal Vaccine Revenue Market Share by Region (2017-2022) Table 45. APAC 23-valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units) Table 46. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022) Table 47. APAC 23-valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units) Table 48. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022) Table 49. Europe 23-valent Pneumococcal Vaccine Sales by Country (2017-2022) & (K Units) Table 50. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Country (2017-2022) Table 51. Europe 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 52. Europe 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2017-2022) Table 53. Europe 23-valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units) Table 54. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022) Table 55. Europe 23-valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units) Table 56. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022) Table 57. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Country (2017-2022) & (K Units) Table 58. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Country (2017-2022) Table 59. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 60. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2017-2022) Table 61. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units) Table 62. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022) Table 63. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units) Table 64. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022) Table 65. Key Market Drivers & Growth Opportunities of 23-valent Pneumococcal Vaccine Table 66. Key Market Challenges & Risks of 23-valent Pneumococcal Vaccine Table 67. Key Industry Trends of 23-valent Pneumococcal Vaccine Table 68. 23-valent Pneumococcal Vaccine Raw Material Table 69. Key Suppliers of Raw Materials Table 70. 23-valent Pneumococcal Vaccine Distributors List Table 71. 23-valent Pneumococcal Vaccine Customer List Table 72. Global 23-valent Pneumococcal Vaccine Sales Forecast by Region (2023-2028) & (K Units) Table 73. Global 23-valent Pneumococcal Vaccine Sales Market Forecast by Region Table 74. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Region (2023-2028) & ($ millions) Table 75. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Region (2023-2028) Table 76. Americas 23-valent Pneumococcal Vaccine Sales Forecast by Country (2023-2028) & (K Units) Table 77. Americas 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 78. APAC 23-valent Pneumococcal Vaccine Sales Forecast by Region (2023-2028) & (K Units) Table 79. APAC 23-valent Pneumococcal Vaccine Revenue Forecast by Region (2023-2028) & ($ millions) Table 80. Europe 23-valent Pneumococcal Vaccine Sales Forecast by Country (2023-2028) & (K Units) Table 81. Europe 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 82. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Forecast by Country (2023-2028) & (K Units) Table 83. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 84. Global 23-valent Pneumococcal Vaccine Sales Forecast by Type (2023-2028) & (K Units) Table 85. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Type (2023-2028) Table 86. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions) Table 87. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Type (2023-2028) Table 88. Global 23-valent Pneumococcal Vaccine Sales Forecast by Application (2023-2028) & (K Units) Table 89. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Application (2023-2028) Table 90. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions) Table 91. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Application (2023-2028) Table 92. Merck Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors Table 93. Merck 23-valent Pneumococcal Vaccine Product Offered Table 94. Merck 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 95. Merck Main Business Table 96. Merck Latest Developments Table 97. Sanofipasteur Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors Table 98. Sanofipasteur 23-valent Pneumococcal Vaccine Product Offered Table 99. Sanofipasteur 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 100. Sanofipasteur Main Business Table 101. Sanofipasteur Latest Developments Table 102. CDIBP Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors Table 103. CDIBP 23-valent Pneumococcal Vaccine Product Offered Table 104. CDIBP 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 105. CDIBP Main Business Table 106. CDIBP Latest Developments Table 107. Kexing Bio Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors Table 108. Kexing Bio 23-valent Pneumococcal Vaccine Product Offered Table 109. Kexing Bio 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 110. Kexing Bio Main Business Table 111. Kexing Bio Latest Developments Table 112. Changsheng Bio-Technology Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors Table 113. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Offered Table 114. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 115. Changsheng Bio-Technology Main Business Table 116. Changsheng Bio-Technology Latest Developments Table 117. Huaan Science and Technology Innovation Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors Table 118. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Offered Table 119. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 120. Huaan Science and Technology Innovation Main Business Table 121. Huaan Science and Technology Innovation Latest Developments List of Figures Figure 1. Picture of 23-valent Pneumococcal Vaccine Figure 2. 23-valent Pneumococcal Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global 23-valent Pneumococcal Vaccine Sales Growth Rate 2017-2028 (K Units) Figure 7. Global 23-valent Pneumococcal Vaccine Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. 23-valent Pneumococcal Vaccine Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of Single Dose Vial Figure 10. Product Picture of Pre-filled Syringe Figure 11. Global 23-valent Pneumococcal Vaccine Sales Market Share by Type in 2021 Figure 12. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Type (2017-2022) Figure 13. 23-valent Pneumococcal Vaccine Consumed in Chronic Cardiovascular Disease Figure 14. Global 23-valent Pneumococcal Vaccine Market: Chronic Cardiovascular Disease (2017-2022) & (K Units) Figure 15. 23-valent Pneumococcal Vaccine Consumed in Chronic Lung Disease Figure 16. Global 23-valent Pneumococcal Vaccine Market: Chronic Lung Disease (2017-2022) & (K Units) Figure 17. 23-valent Pneumococcal Vaccine Consumed in Chronic Liver Disease Figure 18. Global 23-valent Pneumococcal Vaccine Market: Chronic Liver Disease (2017-2022) & (K Units) Figure 19. 23-valent Pneumococcal Vaccine Consumed in People Living with Hiv Figure 20. Global 23-valent Pneumococcal Vaccine Market: People Living with Hiv (2017-2022) & (K Units) Figure 21. 23-valent Pneumococcal Vaccine Consumed in Leukemia Figure 22. Global 23-valent Pneumococcal Vaccine Market: Leukemia (2017-2022) & (K Units) Figure 23. 23-valent Pneumococcal Vaccine Consumed in Lymphoma Figure 24. Global 23-valent Pneumococcal Vaccine Market: Lymphoma (2017-2022) & (K Units) Figure 25. 23-valent Pneumococcal Vaccine Consumed in Multiple Myeloma Figure 26. Global 23-valent Pneumococcal Vaccine Market: Multiple Myeloma (2017-2022) & (K Units) Figure 27. 23-valent Pneumococcal Vaccine Consumed in General Malignancy Figure 28. Global 23-valent Pneumococcal Vaccine Market: General Malignancy (2017-2022) & (K Units) Figure 29. 23-valent Pneumococcal Vaccine Consumed in Chronic Kidney Disease Figure 30. Global 23-valent Pneumococcal Vaccine Market: Chronic Kidney Disease (2017-2022) & (K Units) Figure 31. 23-valent Pneumococcal Vaccine Consumed in Other Figure 32. Global 23-valent Pneumococcal Vaccine Market: Other (2017-2022) & (K Units) Figure 33. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022) Figure 34. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Application in 2021 Figure 35. 23-valent Pneumococcal Vaccine Revenue Market by Company in 2021 ($ Million) Figure 36. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company in 2021 Figure 37. Global 23-valent Pneumococcal Vaccine Sales Market Share by Geographic Region (2017-2022) Figure 38. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Geographic Region in 2021 Figure 39. Global 23-valent Pneumococcal Vaccine Sales Market Share by Region (2017-2022) Figure 40. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Country/Region in 2021 Figure 41. Americas 23-valent Pneumococcal Vaccine Sales 2017-2022 (K Units) Figure 42. Americas 23-valent Pneumococcal Vaccine Revenue 2017-2022 ($ Millions) Figure 43. APAC 23-valent Pneumococcal Vaccine Sales 2017-2022 (K Units) Figure 44. APAC 23-valent Pneumococcal Vaccine Revenue 2017-2022 ($ Millions) Figure 45. Europe 23-valent Pneumococcal Vaccine Sales 2017-2022 (K Units) Figure 46. Europe 23-valent Pneumococcal Vaccine Revenue 2017-2022 ($ Millions) Figure 47. Middle East & Africa 23-valent Pneumococcal Vaccine Sales 2017-2022 (K Units) Figure 48. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue 2017-2022 ($ Millions) Figure 49. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2021 Figure 50. Americas 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2021 Figure 51. United States 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 52. Canada 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 53. Mexico 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 54. Brazil 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 55. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Region in 2021 Figure 56. APAC 23-valent Pneumococcal Vaccine Revenue Market Share by Regions in 2021 Figure 57. China 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 58. Japan 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 59. South Korea 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 60. Southeast Asia 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 61. India 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 62. Australia 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 63. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2021 Figure 64. Europe 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2021 Figure 65. Germany 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 66. France 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 67. UK 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 68. Italy 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 69. Russia 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 70. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2021 Figure 71. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2021 Figure 72. Egypt 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 73. South Africa 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 74. Israel 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 75. Turkey 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 76. GCC Country 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 77. Manufacturing Cost Structure Analysis of 23-valent Pneumococcal Vaccine in 2021 Figure 78. Manufacturing Process Analysis of 23-valent Pneumococcal Vaccine Figure 79. Industry Chain Structure of 23-valent Pneumococcal Vaccine Figure 80. Channels of Distribution Figure 81. Distributors Profiles
As the global economy mends, the 2021 growth of 13-Valent Pneumococcal Polysaccharide Conjugate V ... Read More
As the global economy mends, the 2021 growth of Hot and Sour Noodles will have significant change ... Read More
As the global economy mends, the 2021 growth of Automotive Exhaust Catalytic Materials will have ... Read More